China Medicine Renews Contract with CCG Investor Relations
... as one of "863" key projects starting commercialization after more than ten years of research and incubation. "The harmful threat of aflatoxins presents an opportunity for China Medicine to increase the quality and standard of animal feed and human food," commented Crocker Coulson, President ...China Medicine Corporation Obtains Australian Patent for rADTZ
... enzyme. Developed by Guangzhou Co-Win Bioengineering Co., Ltd, a subsidiary of China Medicine, rADTZ can be used as an additive to remove aflatoxins from animal feed as well as other food products. The Company intends to develop rADTZ for this and other applications. "We are proud to announce ...Improved method developed to test carcinogen risk
... accurate. "The EPA levels of exposure for both the PAH compound and aflatoxins were determined using essentially the same methodology based on rodent studies," Bailey said. "But our research suggests that the findings for aflatoxins are pretty accurate, while for the PAH compound we're off by a factor of ...